Portunus trituberculatus isolate SZX2019 chromosome 19, ASM1759143v1, whole genome shotgun sequence.
Portunus trituberculatus (swimming crab)
Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Crustacea; Multicrustacea; Malacostraca; Eumalacostraca; Eucarida; Decapoda; Pleocyemata; Brachyura; Eubrachyura; Portunoidea; Portunidae; Portunus.
REFSEQ INFORMATION: The reference sequence is identical to\nCM030089.1.\nAssembly name: ASM1759143v1\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the Center for Ecological and\nEnvironmental Sciences on 2021/03/30. The original whole-genome\nshotgun project has the accession JAGGDN000000000.1.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: Center for Ecological and Environmental\n Sciences\nAssembly Method :: Wtdbg v. 2.1\nGenome Representation :: Full\nExpected Final Version :: Yes\nGenome Coverage :: 54.74x\nSequencing Technology :: Oxford Nanopore; Illumina\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Portunus trituberculatus Annotation\n Release 100\nAnnotation Version :: 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
COORDINATES: polyA evidence [ECO:0006239]
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: alpha-protein kinase 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 91% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC123506070, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC123506070, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
ras-related and estrogen-regulated growth inhibitor-like, transcript variant X2
ras-related and estrogen-regulated growth inhibitor-like, transcript variant X1
ras-related and estrogen-regulated growth inhibitor-like isoform X1
ras-related and estrogen-regulated growth inhibitor-like isoform X2
ras-related and estrogen-regulated growth inhibitor-like, transcript variant X3
proton myo-inositol cotransporter-like, transcript variant X3
proton myo-inositol cotransporter-like, transcript variant X2
proton myo-inositol cotransporter-like, transcript variant X4
proton myo-inositol cotransporter-like, transcript variant X1
proton myo-inositol cotransporter-like isoform X1
proton myo-inositol cotransporter-like isoform X3
proton myo-inositol cotransporter-like isoform X2
uncharacterized LOC123506071, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
uncharacterized LOC123506071, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 long SRA reads, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
uncharacterized LOC123506071, transcript variant X2
uncharacterized protein LOC123506071 isoform X1
uncharacterized protein LOC123506071 isoform X3
uncharacterized protein LOC123506071 isoform X2
uncharacterized LOC123506071, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC123506071, transcript variant X5
uncharacterized protein LOC123506071 isoform X4
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA valine (anticodon AAC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
serine/arginine repetitive matrix protein 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
BTB/POZ domain-containing protein 6-like
transfer RNA glycine (anticodon CCC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
irregular chiasm C-roughest protein-like
cilia- and flagella-associated protein 36-like, transcript variant X2
cilia- and flagella-associated protein 36-like, transcript variant X1
cilia- and flagella-associated protein 36-like, transcript variant X3
cilia- and flagella-associated protein 36-like
transfer RNA arginine (anticodon ACG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
LOW QUALITY PROTEIN: kin of IRRE-like protein 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
beta-arrestin-1-like, transcript variant X6
beta-arrestin-1-like, transcript variant X4
beta-arrestin-1-like, transcript variant X5
beta-arrestin-1-like, transcript variant X3
beta-arrestin-1-like, transcript variant X1
beta-arrestin-1-like, transcript variant X2
transfer RNA arginine (anticodon CCU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
DNA-directed RNA polymerase II subunit rpb1-like
SAGA-associated factor 29-like, transcript variant X1
SAGA-associated factor 29-like, transcript variant X2
SAGA-associated factor 29-like isoform X1
SAGA-associated factor 29-like isoform X2
uncharacterized LOC123506281, transcript variant X4
uncharacterized LOC123506281, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uncharacterized LOC123506281, transcript variant X3
uncharacterized LOC123506281, transcript variant X2
probable G-protein coupled receptor Mth-like 1, transcript variant X3
probable G-protein coupled receptor Mth-like 1, transcript variant X1
probable G-protein coupled receptor Mth-like 1, transcript variant X2
probable G-protein coupled receptor Mth-like 1, transcript variant X6
probable G-protein coupled receptor Mth-like 1 isoform X2
probable G-protein coupled receptor Mth-like 1 isoform X1
probable G-protein coupled receptor Mth-like 1 isoform X4
probable G-protein coupled receptor Mth-like 1, transcript variant X4
probable G-protein coupled receptor Mth-like 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
probable G-protein coupled receptor Mth-like 1 isoform X3
transfer RNA tryptophan (anticodon CCA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, and 99% coverage of the annotated genomic feature by RNAseq alignments
nascent polypeptide-associated complex subunit alpha, muscle-specific form-like, transcript variant X2
nascent polypeptide-associated complex subunit alpha, muscle-specific form-like isoform X2
nascent polypeptide-associated complex subunit alpha, muscle-specific form-like, transcript variant X1
nascent polypeptide-associated complex subunit alpha, muscle-specific form-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
nascent polypeptide-associated complex subunit alpha, muscle-specific form-like isoform X1
nascent polypeptide-associated complex subunit alpha, muscle-specific form-like isoform X3
regulator of G-protein signaling 2-like, transcript variant X1
regulator of G-protein signaling 2-like, transcript variant X2
uncharacterized protein LOC123505992 isoform X1
regulator of G-protein signaling 2-like isoform X2
CCR4-NOT transcription complex subunit 10-A-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
CCR4-NOT transcription complex subunit 10-A-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
CCR4-NOT transcription complex subunit 10-A-like, transcript variant X1
CCR4-NOT transcription complex subunit 10-A-like
JNK1/MAPK8-associated membrane protein-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 long SRA reads, 35 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
JNK1/MAPK8-associated membrane protein-like, transcript variant X1
JNK1/MAPK8-associated membrane protein-like isoform X2
JNK1/MAPK8-associated membrane protein-like isoform X1
transfer RNA methionine (anticodon CAU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
p21-activated protein kinase-interacting protein 1-like
chromodomain-helicase-DNA-binding protein Mi-2 homolog
ectonucleotide pyrophosphatase/phosphodiesterase family member 3-like
U6 snRNA-associated Sm-like protein LSm2
Krueppel homolog 1-like, transcript variant X2
Krueppel homolog 1-like, transcript variant X1
Krueppel homolog 1-like, transcript variant X3
protein jagged-1b-like, transcript variant X4
protein jagged-1b-like, transcript variant X1
protein jagged-1b-like, transcript variant X2
protein jagged-1b-like, transcript variant X3
40S ribosomal protein S19-like, transcript variant X2
40S ribosomal protein S19-like, transcript variant X1
40S ribosomal protein S19-like isoform X2
40S ribosomal protein S19-like isoform X1
vacuolar protein sorting-associated protein 26C-like, transcript variant X2
vacuolar protein sorting-associated protein 26C-like, transcript variant X1
vacuolar protein sorting-associated protein 26C-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
60S ribosomal protein L14-like, transcript variant X2
60S ribosomal protein L14-like, transcript variant X1
60S ribosomal protein L14-like isoform X1
60S ribosomal protein L14-like isoform X2
transcription elongation factor 1 homolog
uncharacterized LOC123506038, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
uncharacterized LOC123506038, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized protein LOC123506038 isoform X2
uncharacterized protein LOC123506038 isoform X1
facilitated trehalose transporter Tret1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 82% coverage of the annotated genomic feature by RNAseq alignments
leucine-rich PPR motif-containing protein, mitochondrial-like, transcript variant X2
leucine-rich PPR motif-containing protein, mitochondrial-like, transcript variant X1
leucine-rich PPR motif-containing protein, mitochondrial-like isoform X1
leucine-rich PPR motif-containing protein, mitochondrial-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
transfer RNA glutamic acid (anticodon UUC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
alanine racemase-like, transcript variant X2
alanine racemase-like, transcript variant X1
alanine racemase-like, transcript variant X3
alanine racemase-like, transcript variant X4
LOW QUALITY PROTEIN: uncharacterized protein LOC123506006
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 10 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
ras-related protein Rap-2c-like, transcript variant X1
ras-related protein Rap-2c-like, transcript variant X2
transmembrane protein 184C-like, transcript variant X2
transmembrane protein 184C-like, transcript variant X1
uncharacterized LOC123506029, transcript variant X1
uncharacterized LOC123506029, transcript variant X2
acyl-coenzyme A synthetase ACSM3, mitochondrial-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 long SRA reads, 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
acyl-coenzyme A synthetase ACSM3, mitochondrial-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 long SRA reads, 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
acyl-coenzyme A synthetase ACSM3, mitochondrial-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 long SRA reads, 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
acyl-coenzyme A synthetase ACSM3, mitochondrial-like isoform X1
acyl-coenzyme A synthetase ACSM3, mitochondrial-like isoform X2
uncharacterized LOC123506116, transcript variant X2
uncharacterized LOC123506116, transcript variant X3
uncharacterized LOC123506116, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
uncharacterized protein LOC123506116 isoform X2
uncharacterized protein LOC123506116 isoform X1
uncharacterized LOC123506115, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
uncharacterized protein LOC123506115 isoform X3
uncharacterized LOC123506115, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
uncharacterized LOC123506115, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
uncharacterized protein LOC123506115 isoform X2
uncharacterized protein LOC123506115 isoform X1
transfer RNA histidin (anticodon GUG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
uncharacterized LOC123506325, transcript variant X1
uncharacterized LOC123506325, transcript variant X2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 57% coverage of the annotated genomic feature by RNAseq alignments
SEC14 domain and spectrin repeat-containing protein 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
SEC14 domain and spectrin repeat-containing protein 1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
SEC14 domain and spectrin repeat-containing protein 1-like, transcript variant X2
SEC14 domain and spectrin repeat-containing protein 1-like
NPC intracellular cholesterol transporter 2 homolog a-like
tetratricopeptide repeat protein 19, mitochondrial-like
haloacid dehalogenase-like hydrolase domain-containing protein 3, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
haloacid dehalogenase-like hydrolase domain-containing protein 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
haloacid dehalogenase-like hydrolase domain-containing protein 3, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
haloacid dehalogenase-like hydrolase domain-containing protein 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
haloacid dehalogenase-like hydrolase domain-containing protein 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
haloacid dehalogenase-like hydrolase domain-containing protein 3 isoform X2
haloacid dehalogenase-like hydrolase domain-containing protein 3 isoform X1
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00319
telomere length and silencing protein 1 homolog, transcript variant X5
telomere length and silencing protein 1 homolog, transcript variant X2
telomere length and silencing protein 1 homolog, transcript variant X6
telomere length and silencing protein 1 homolog, transcript variant X3
telomere length and silencing protein 1 homolog, transcript variant X4
telomere length and silencing protein 1 homolog, transcript variant X1
telomere length and silencing protein 1 homolog isoform X1
telomere length and silencing protein 1 homolog isoform X2
thioredoxin-related transmembrane protein 2 homolog
probable aminopeptidase NPEPL1, transcript variant X2
probable aminopeptidase NPEPL1, transcript variant X1
probable aminopeptidase NPEPL1, transcript variant X3
2-oxo-4-hydroxy-4-carboxy-5-ureidoimidazoline decarboxylase-like
nuclear pore glycoprotein p62-like, transcript variant X1
nuclear pore glycoprotein p62-like, transcript variant X2
protein disulfide-isomerase A4-like, transcript variant X2
protein disulfide-isomerase A4-like, transcript variant X3
protein disulfide-isomerase A4-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
proteasome activator complex subunit 3-like
peptidyl-glycine alpha-amidating monooxygenase B-like, transcript variant X4
peptidyl-glycine alpha-amidating monooxygenase B-like, transcript variant X2
peptidyl-glycine alpha-amidating monooxygenase B-like, transcript variant X3
peptidyl-glycine alpha-amidating monooxygenase B-like, transcript variant X1
peptidyl-glycine alpha-amidating monooxygenase B-like isoform X2
peptidyl-glycine alpha-amidating monooxygenase B-like isoform X3
peptidyl-glycine alpha-amidating monooxygenase B-like isoform X1
peptidyl-glycine alpha-amidating monooxygenase B-like isoform X4
peptidyl-glycine alpha-amidating monooxygenase B-like, transcript variant X5
peptidyl-glycine alpha-amidating monooxygenase B-like isoform X5
transcription intermediary factor 1-alpha-like
ras-related protein ced-10-like, transcript variant X1
ras-related protein ced-10-like, transcript variant X2
hydroxysteroid dehydrogenase-like protein 2
RNA polymerase-associated protein Rtf1-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: RNA polymerase-associated protein Rtf1-like
mitochondrial import inner membrane translocase subunit TIM44-like
LOW QUALITY PROTEIN: mitochondrial import inner membrane translocase subunit TIM44-like
uncharacterized LOC123506204, transcript variant X2
uncharacterized LOC123506204, transcript variant X1
protein amalgam-like, transcript variant X2
protein amalgam-like, transcript variant X3
protein amalgam-like, transcript variant X1
protein amalgam-like, transcript variant X4
protein amalgam-like, transcript variant X5
protein O-mannosyl-transferase TMTC1-like, transcript variant X1
protein O-mannosyl-transferase TMTC1-like, transcript variant X3
protein O-mannosyl-transferase TMTC1-like, transcript variant X2
protein O-mannosyl-transferase TMTC1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 99% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized LOC123506061, transcript variant X2
uncharacterized LOC123506061, transcript variant X1
uncharacterized protein LOC123506061 isoform X2
uncharacterized protein LOC123506061 isoform X1
neuropeptide SIFamide receptor-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
neuropeptide SIFamide receptor-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 long SRA reads, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
neuropeptide SIFamide receptor-like isoform X2
neuropeptide SIFamide receptor-like isoform X1
origin recognition complex subunit 1-like, transcript variant X3
origin recognition complex subunit 1-like, transcript variant X1
origin recognition complex subunit 1-like, transcript variant X2
origin recognition complex subunit 1-like isoform X3
origin recognition complex subunit 1-like isoform X1
origin recognition complex subunit 1-like isoform X2
sulfotransferase 1 family member D1-like
MAP kinase-activated protein kinase 2-like
chitobiosyldiphosphodolichol beta-mannosyltransferase-like
LOW QUALITY PROTEIN: chitobiosyldiphosphodolichol beta-mannosyltransferase-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 long SRA reads, 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
long-chain-fatty-acid--CoA ligase 1-like, transcript variant X3
long-chain-fatty-acid--CoA ligase 1-like, transcript variant X4
long-chain-fatty-acid--CoA ligase 1-like, transcript variant X2
long-chain-fatty-acid--CoA ligase 1-like, transcript variant X1
long-chain-fatty-acid--CoA ligase 1-like, transcript variant X5
long-chain-fatty-acid--CoA ligase 1-like, transcript variant X6
long-chain-fatty-acid--CoA ligase 1-like isoform X2
long-chain-fatty-acid--CoA ligase 5-like isoform X1
long-chain-fatty-acid--CoA ligase 1-like isoform X3
long-chain-fatty-acid--CoA ligase 1-like isoform X4
uncharacterized LOC123506117, transcript variant X2
uncharacterized protein LOC123506117 isoform X2
uncharacterized LOC123506117, transcript variant X1
uncharacterized protein LOC123506117 isoform X1
zinc finger and BTB domain-containing protein 24-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 39 samples with support for all annotated introns
zinc finger and BTB domain-containing protein 24-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
zinc finger and BTB domain-containing protein 24-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
zinc finger and BTB domain-containing protein 24-like
endothelial zinc finger protein induced by tumor necrosis factor alpha-like, transcript variant X1
endothelial zinc finger protein induced by tumor necrosis factor alpha-like, transcript variant X3
endothelial zinc finger protein induced by tumor necrosis factor alpha-like, transcript variant X4
endothelial zinc finger protein induced by tumor necrosis factor alpha-like, transcript variant X2
endothelial zinc finger protein induced by tumor necrosis factor alpha-like
zinc finger and SCAN domain-containing protein 22-like, transcript variant X2
zinc finger and SCAN domain-containing protein 22-like, transcript variant X1
zinc finger and SCAN domain-containing protein 22-like
zinc finger protein 91-like, transcript variant X1
zinc finger protein 91-like, transcript variant X2
monocarboxylate transporter 9-like, transcript variant X1
monocarboxylate transporter 9-like, transcript variant X2
monocarboxylate transporter 9-like isoform X1
monocarboxylate transporter 9-like, transcript variant X3
uncharacterized protein LOC123506274 isoform X2
zinc finger and BTB domain-containing protein 41-like, transcript variant X2
zinc finger and BTB domain-containing protein 41-like, transcript variant X1
zinc finger and BTB domain-containing protein 41-like, transcript variant X4
zinc finger and BTB domain-containing protein 41-like, transcript variant X5
uncharacterized protein LOC123506199 isoform X4
zinc finger and BTB domain-containing protein 41-like, transcript variant X3
zinc finger and BTB domain-containing protein 41-like isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 long SRA reads, 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
zinc finger protein 184-like, transcript variant X2
zinc finger protein 184-like, transcript variant X3
zinc finger protein 184-like, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 long SRA reads, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
zinc finger protein 184-like, transcript variant X7
zinc finger protein 184-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 long SRA reads, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
zinc finger protein 184-like, transcript variant X9
zinc finger protein 184-like, transcript variant X1
uncharacterized protein LOC123506110 isoform X5
uncharacterized protein LOC123506110 isoform X4
uncharacterized protein LOC123506110 isoform X1
zinc finger protein 184-like, transcript variant X5
zinc finger protein 184-like, transcript variant X4
uncharacterized protein LOC123506110 isoform X2
transfer RNA proline (anticodon UGG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA leucine (anticodon AAG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads
uncharacterized LOC123506308, transcript variant X2
uncharacterized LOC123506308, transcript variant X1
uncharacterized LOC123506307, transcript variant X3
uncharacterized LOC123506307, transcript variant X1
uncharacterized LOC123506307, transcript variant X2
uncharacterized LOC123506307, transcript variant X5
uncharacterized protein LOC123506307 isoform X2
uncharacterized protein LOC123506307 isoform X1
uncharacterized protein LOC123506307 isoform X4
uncharacterized LOC123506307, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 long SRA reads, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
uncharacterized protein LOC123506307 isoform X3
ribosomal L1 domain-containing protein 1-like
nuclear pore complex protein Nup153-like
uncharacterized LOC123506149, transcript variant X1
uncharacterized LOC123506149, transcript variant X3
uncharacterized LOC123506149, transcript variant X2
uncharacterized protein LOC123506149 isoform X1
uncharacterized protein LOC123506149 isoform X3
uncharacterized protein LOC123506149 isoform X2
PR domain zinc finger protein 5-like, transcript variant X1
PR domain zinc finger protein 5-like, transcript variant X2
probable bifunctional dTTP/UTP pyrophosphatase/methyltransferase protein, transcript variant X1
probable bifunctional dTTP/UTP pyrophosphatase/methyltransferase protein, transcript variant X3
probable bifunctional dTTP/UTP pyrophosphatase/methyltransferase protein, transcript variant X4
probable bifunctional dTTP/UTP pyrophosphatase/methyltransferase protein, transcript variant X2
probable bifunctional dTTP/UTP pyrophosphatase/methyltransferase protein isoform X2
probable bifunctional dTTP/UTP pyrophosphatase/methyltransferase protein isoform X1
neuronal acetylcholine receptor subunit alpha-7-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 long SRA reads, 5 Proteins, and 89% coverage of the annotated genomic feature by RNAseq alignments
zinc finger protein 501-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, and 95% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
zinc finger protein 501-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
mitochondrial 2-oxodicarboxylate carrier-like, transcript variant X4
mitochondrial 2-oxodicarboxylate carrier-like, transcript variant X2
mitochondrial 2-oxodicarboxylate carrier-like, transcript variant X1
mitochondrial 2-oxodicarboxylate carrier-like, transcript variant X5
mitochondrial 2-oxodicarboxylate carrier-like, transcript variant X3
mitochondrial 2-oxodicarboxylate carrier-like isoform X1
mitochondrial 2-oxodicarboxylate carrier-like isoform X2
poly(A)-specific ribonuclease PARN-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
poly(A)-specific ribonuclease PARN-like isoform X3
poly(A)-specific ribonuclease PARN-like, transcript variant X3
poly(A)-specific ribonuclease PARN-like, transcript variant X1
poly(A)-specific ribonuclease PARN-like, transcript variant X9
poly(A)-specific ribonuclease PARN-like, transcript variant X8
poly(A)-specific ribonuclease PARN-like, transcript variant X7
poly(A)-specific ribonuclease PARN-like, transcript variant X6
poly(A)-specific ribonuclease PARN-like, transcript variant X4
poly(A)-specific ribonuclease PARN-like, transcript variant X2
poly(A)-specific ribonuclease PARN-like isoform X1
poly(A)-specific ribonuclease PARN-like isoform X4
poly(A)-specific ribonuclease PARN-like isoform X2
poly(A)-specific ribonuclease PARN-like isoform X5
TRAF3-interacting protein 1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
TRAF3-interacting protein 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 long SRA reads, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
TRAF3-interacting protein 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
TRAF3-interacting protein 1-like isoform X3
TRAF3-interacting protein 1-like isoform X2
TRAF3-interacting protein 1-like isoform X1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: centrosomal protein of 290 kDa-like
uncharacterized LOC123506217, transcript variant X3
uncharacterized LOC123506217, transcript variant X2
uncharacterized LOC123506217, transcript variant X1
uncharacterized LOC123506368, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
uncharacterized LOC123506368, transcript variant X1
uncharacterized protein LOC123506368 isoform X1
uncharacterized protein LOC123506368 isoform X2
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon; substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: uncharacterized protein LOC123506371
ras-related and estrogen-regulated growth inhibitor-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 long SRA reads, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
uncharacterized LOC123506341, transcript variant X6
uncharacterized LOC123506341, transcript variant X4
uncharacterized LOC123506341, transcript variant X7
uncharacterized LOC123506341, transcript variant X9
uncharacterized LOC123506341, transcript variant X2
uncharacterized LOC123506341, transcript variant X3
uncharacterized LOC123506341, transcript variant X10
uncharacterized LOC123506341, transcript variant X1
uncharacterized LOC123506341, transcript variant X8
uncharacterized LOC123506341, transcript variant X5
uncharacterized protein LOC123506341 isoform X2
uncharacterized protein LOC123506341 isoform X1
protein O-linked-mannose beta-1,2-N-acetylglucosaminyltransferase 1-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 9 Proteins, and 86% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
LOW QUALITY PROTEIN: protein O-linked-mannose beta-1,2-N-acetylglucosaminyltransferase 1-like
protein O-linked-mannose beta-1,2-N-acetylglucosaminyltransferase 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 6 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
protein O-linked-mannose beta-1,2-N-acetylglucosaminyltransferase 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 long SRA reads, 9 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
protein O-linked-mannose beta-1,2-N-acetylglucosaminyltransferase 1-like isoform X1
protein O-linked-mannose beta-1,2-N-acetylglucosaminyltransferase 1-like isoform X2
uncharacterized LOC123506347, transcript variant X3
uncharacterized LOC123506347, transcript variant X5
uncharacterized LOC123506347, transcript variant X4
uncharacterized LOC123506347, transcript variant X8
uncharacterized LOC123506347, transcript variant X1
uncharacterized LOC123506347, transcript variant X6
uncharacterized LOC123506347, transcript variant X7
uncharacterized LOC123506347, transcript variant X9
uncharacterized LOC123506347, transcript variant X10
uncharacterized LOC123506347, transcript variant X11
uncharacterized LOC123506347, transcript variant X12
uncharacterized LOC123506347, transcript variant X13
uncharacterized LOC123506347, transcript variant X15
uncharacterized LOC123506347, transcript variant X2
uncharacterized LOC123506347, transcript variant X14
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins
uncharacterized protein LOC123506347 isoform X1
uncharacterized protein LOC123506347 isoform X5
uncharacterized protein LOC123506347 isoform X2
uncharacterized protein LOC123506347 isoform X6
uncharacterized protein LOC123506347 isoform X7
uncharacterized protein LOC123506347 isoform X3
uncharacterized protein LOC123506347 isoform X8
uncharacterized protein LOC123506347 isoform X10
uncharacterized protein LOC123506347 isoform X9
uncharacterized protein LOC123506347 isoform X11
uncharacterized protein LOC123506347 isoform X4
TGF-beta-activated kinase 1 and MAP3K7-binding protein 1-like, transcript variant X1
TGF-beta-activated kinase 1 and MAP3K7-binding protein 1-like, transcript variant X2
TGF-beta-activated kinase 1 and MAP3K7-binding protein 1-like isoform X1
TGF-beta-activated kinase 1 and MAP3K7-binding protein 1-like isoform X2
uncharacterized LOC123506350, transcript variant X2
uncharacterized LOC123506350, transcript variant X1
uncharacterized LOC123506350, transcript variant X4
uncharacterized LOC123506350, transcript variant X5
uncharacterized LOC123506350, transcript variant X3
uncharacterized LOC123506354, transcript variant X9
uncharacterized LOC123506354, transcript variant X5
uncharacterized LOC123506354, transcript variant X1
uncharacterized LOC123506354, transcript variant X8
uncharacterized LOC123506354, transcript variant X3
uncharacterized LOC123506354, transcript variant X7
uncharacterized LOC123506354, transcript variant X2
uncharacterized LOC123506354, transcript variant X6
uncharacterized LOC123506354, transcript variant X4
uncharacterized protein LOC123506350 isoform X1
uncharacterized protein LOC123506350 isoform X2
uncharacterized LOC123506353, transcript variant X1
uncharacterized protein LOC123506353 isoform X1
uncharacterized LOC123506353, transcript variant X2
uncharacterized protein LOC123506353 isoform X2
uncharacterized LOC123506352, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
uncharacterized LOC123506352, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
uncharacterized protein LOC123506352 isoform X1
uncharacterized protein LOC123506352 isoform X2
acetyl-CoA acetyltransferase, cytosolic-like
MAP7 domain-containing protein 1-like, transcript variant X8
MAP7 domain-containing protein 1-like, transcript variant X2
MAP7 domain-containing protein 1-like, transcript variant X4
MAP7 domain-containing protein 1-like, transcript variant X9
MAP7 domain-containing protein 1-like, transcript variant X7
MAP7 domain-containing protein 1-like, transcript variant X6
MAP7 domain-containing protein 1-like, transcript variant X1
MAP7 domain-containing protein 1-like, transcript variant X3
MAP7 domain-containing protein 1-like, transcript variant X10
MAP7 domain-containing protein 1-like, transcript variant X5
MAP7 domain-containing protein 1-like isoform X7
MAP7 domain-containing protein 2-like isoform X8
MAP7 domain-containing protein 1-like isoform X2
MAP7 domain-containing protein 1-like isoform X6
MAP7 domain-containing protein 1-like isoform X9
MAP7 domain-containing protein 1-like isoform X3
MAP7 domain-containing protein 1-like isoform X5
probable methylmalonate-semialdehyde dehydrogenase [acylating], mitochondrial
tripeptidyl-peptidase 2-like, transcript variant X2
tripeptidyl-peptidase 2-like, transcript variant X1
uncharacterized LOC123506363, transcript variant X2
uncharacterized LOC123506363, transcript variant X1
uncharacterized protein LOC123506363 isoform X1
uncharacterized protein LOC123506363 isoform X2
E3 ubiquitin-protein ligase Mdm2-like, transcript variant X1
E3 ubiquitin-protein ligase Mdm2-like, transcript variant X2
E3 ubiquitin-protein ligase Mdm2-like, transcript variant X3
E3 ubiquitin-protein ligase Mdm2-like, transcript variant X4
E3 ubiquitin-protein ligase Mdm2-like isoform X1
uncharacterized protein LOC123506016 isoform X2
E3 ubiquitin-protein ligase Mdm2-like isoform X3
kinesin-like protein KIF12, transcript variant X2
kinesin-like protein KIF12, transcript variant X1
kinesin-like protein KIF12, transcript variant X7
kinesin-like protein KIF12, transcript variant X5
kinesin-like protein KIF12, transcript variant X3
kinesin-like protein KIF12, transcript variant X4
kinesin-like protein KIF12, transcript variant X6
cell wall integrity and stress response component 1-like, transcript variant X1
cell wall integrity and stress response component 1-like, transcript variant X2
cell wall integrity and stress response component 1-like isoform X2
cell wall integrity and stress response component 1-like isoform X1
serine/threonine-protein kinase DCLK1-like
LOW QUALITY PROTEIN: serine/threonine-protein kinase DCLK1-like
glycine-rich protein A3-like, transcript variant X1
glycine-rich protein A3-like, transcript variant X2
N-lysine methyltransferase SMYD2-A-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
N-lysine methyltransferase SMYD2-A-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 long SRA reads, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
N-lysine methyltransferase SMYD2-A-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
N-lysine methyltransferase SMYD2-A-like isoform X2
uncharacterized protein LOC123506141 isoform X1
uncharacterized protein LOC123506141 isoform X3
transfer RNA valine (anticodon GAC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA phenylalanine (anticodon GAA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
proline-rich receptor-like protein kinase PERK10
uncharacterized LOC123506263, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
uncharacterized LOC123506263, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
uncharacterized protein LOC123506263 isoform X1
uncharacterized protein LOC123506263 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 34% coverage of the annotated genomic feature by RNAseq alignments
F-box/LRR-repeat protein 4-like, transcript variant X5
F-box/LRR-repeat protein 4-like, transcript variant X1
F-box/LRR-repeat protein 4-like, transcript variant X4
F-box/LRR-repeat protein 4-like, transcript variant X2
F-box/LRR-repeat protein 4-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 long SRA reads, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 90% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
abasic site processing protein HMCES-like
decapping and exoribonuclease protein-like
LOW QUALITY PROTEIN: decapping and exoribonuclease protein-like
potassium channel subfamily K member 1-like, transcript variant X2
potassium channel subfamily K member 1-like isoform X2
potassium channel subfamily K member 1-like, transcript variant X1
potassium channel subfamily K member 6-like isoform X1
leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 3, transcript variant X11
leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 3, transcript variant X6
leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 3, transcript variant X1
leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 3, transcript variant X5
leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 3, transcript variant X2
leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 3, transcript variant X3
leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 3, transcript variant X7
leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 3, transcript variant X10
leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 3, transcript variant X8
leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 3, transcript variant X4
leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 3, transcript variant X9
leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, 5 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
pigment-dispersing hormone 2 peptides-like, transcript variant X1
pigment-dispersing hormone 2 peptides-like, transcript variant X2
pigment-dispersing hormone 2 peptides-like
pigment-dispersing hormone 2 peptides-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
pigment-dispersing hormone 1 peptides, transcript variant X2
pigment-dispersing hormone 1 peptides, transcript variant X1
electron transfer flavoprotein beta subunit lysine methyltransferase-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
electron transfer flavoprotein beta subunit lysine methyltransferase-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
electron transfer flavoprotein beta subunit lysine methyltransferase-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
electron transfer flavoprotein beta subunit lysine methyltransferase-like
LOW QUALITY PROTEIN: aspartate aminotransferase-like
uncharacterized LOC123506056, transcript variant X2
uncharacterized LOC123506056, transcript variant X1
WD repeat and FYVE domain-containing protein 2-like
alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A-like, transcript variant X2
alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A-like, transcript variant X3
alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A-like, transcript variant X1
alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A-like isoform X1
alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A-like isoform X2
alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A-like isoform X3
schwannomin-interacting protein 1-like, transcript variant X3
schwannomin-interacting protein 1-like, transcript variant X1
schwannomin-interacting protein 1-like, transcript variant X2
uncharacterized protein LOC123506193 isoform X1
uncharacterized protein LOC123506193 isoform X3
schwannomin-interacting protein 1-like isoform X2
alpha-(1,3)-fucosyltransferase C-like, transcript variant X4
alpha-(1,3)-fucosyltransferase C-like, transcript variant X2
alpha-(1,3)-fucosyltransferase C-like, transcript variant X1
alpha-(1,3)-fucosyltransferase C-like, transcript variant X5
alpha-(1,3)-fucosyltransferase C-like, transcript variant X3
glycoprotein 3-alpha-L-fucosyltransferase A-like isoform X2
glycoprotein 3-alpha-L-fucosyltransferase A-like isoform X1
alpha-(1,3)-fucosyltransferase C-like isoform X3
alpha-(1,3)-fucosyltransferase C-like isoform X4
tRNA pseudouridine synthase Pus10-like, transcript variant X1
tRNA pseudouridine synthase Pus10-like, transcript variant X2
leucine-rich repeat extensin-like protein 3
retinol dehydrogenase 11-like, transcript variant X2
retinol dehydrogenase 11-like, transcript variant X1
peptidyl-prolyl cis-trans isomerase FKBP62-like
uncharacterized LOC123506180, transcript variant X1
uncharacterized LOC123506180, transcript variant X2
uncharacterized protein LOC123506180 isoform X1
uncharacterized protein LOC123506180 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 2 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC123506276, transcript variant X4
uncharacterized LOC123506276, transcript variant X1
uncharacterized LOC123506276, transcript variant X3
uncharacterized LOC123506276, transcript variant X2
uncharacterized protein LOC123506276 isoform X2
uncharacterized protein LOC123506276 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 71% coverage of the annotated genomic feature by RNAseq alignments
roundabout homolog 3-like, transcript variant X2
roundabout homolog 3-like, transcript variant X5
roundabout homolog 3-like, transcript variant X1
roundabout homolog 3-like, transcript variant X3
roundabout homolog 3-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC123506107, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC123506107, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized LOC123506107, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
transfer RNA asparagine (anticodon AUU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
WD repeat-containing protein 17-like, transcript variant X3
WD repeat-containing protein 17-like, transcript variant X2
WD repeat-containing protein 17-like, transcript variant X1
WD repeat-containing protein 17-like isoform X2
WD repeat-containing protein 17-like isoform X1
WD repeat-containing protein 17-like isoform X3
UDP-glucosyltransferase 2-like, transcript variant X1
UDP-glucosyltransferase 2-like, transcript variant X2
UDP-glucosyltransferase 2-like isoform X1
UDP-glucosyltransferase 2-like, transcript variant X4
UDP-glucosyltransferase 2-like, transcript variant X3
UDP-glucosyltransferase 2-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 79% coverage of the annotated genomic feature by RNAseq alignments
transfer RNA leucine (anticodon CAA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 39% coverage of the annotated genomic feature by RNAseq alignments
LOW QUALITY PROTEIN: uncharacterized protein LOC123506165
transfer RNA alanine (anticodon CGC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
zinc finger BED domain-containing protein 5-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 1 Protein, and 59% coverage of the annotated genomic feature by RNAseq alignments
LOW QUALITY PROTEIN: uncharacterized protein LOC123506261
ribosomal protein S6 kinase beta-1-like, transcript variant X5
ribosomal protein S6 kinase beta-1-like, transcript variant X4
ribosomal protein S6 kinase beta-1-like, transcript variant X7
ribosomal protein S6 kinase beta-1-like, transcript variant X6
ribosomal protein S6 kinase beta-1-like, transcript variant X8
ribosomal protein S6 kinase beta-1-like, transcript variant X3
ribosomal protein S6 kinase beta-1-like, transcript variant X9
ribosomal protein S6 kinase beta-1-like, transcript variant X1
ribosomal protein S6 kinase beta-1-like, transcript variant X2
ribosomal protein S6 kinase beta-1-like isoform X1
ribosomal protein S6 kinase beta-1-like isoform X2
spindle assembly checkpoint kinase-like, transcript variant X1
spindle assembly checkpoint kinase-like isoform X1
splicing factor, suppressor of white-apricot homolog, transcript variant X2
splicing factor, suppressor of white-apricot homolog, transcript variant X1
splicing factor, suppressor of white-apricot homolog isoform X2
splicing factor, suppressor of white-apricot homolog isoform X1
spindle assembly checkpoint kinase-like, transcript variant X2
spindle assembly checkpoint kinase-like isoform X2
LOW QUALITY PROTEIN: beta-hexosaminidase subunit beta-like
beta-hexosaminidase subunit alpha-like, transcript variant X1
beta-hexosaminidase subunit alpha-like, transcript variant X2
uncharacterized protein LOC123506087 isoform X1
beta-hexosaminidase subunit alpha-like isoform X2
ubiquinone biosynthesis monooxygenase COQ6, mitochondrial-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 22% coverage of the annotated genomic feature by RNAseq alignments
serine-rich adhesin for platelets-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
serine-rich adhesin for platelets-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
serine/arginine repetitive matrix protein 2-like isoform X1
serine-rich adhesin for platelets-like isoform X2
protein phosphatase 1K, mitochondrial-like, transcript variant X1
protein phosphatase 1K, mitochondrial-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
protein phosphatase 1K, mitochondrial-like
potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 3-like
transfer RNA valine (anticodon UAC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
uncharacterized LOC123506100, transcript variant X1
uncharacterized LOC123506100, transcript variant X2
26S proteasome non-ATPase regulatory subunit 12-like
COBW domain-containing protein 1-like, transcript variant X2
COBW domain-containing protein 1-like, transcript variant X1
COBW domain-containing protein 1-like isoform X1
COBW domain-containing protein 1-like isoform X2
LOW QUALITY PROTEIN: forkhead box protein D1-like
transfer RNA aspartic acid (anticodon GUC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
insulin-like growth factor-binding protein complex acid labile subunit
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
sphingomyelin phosphodiesterase-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 long SRA reads, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
sphingomyelin phosphodiesterase-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 long SRA reads, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
sphingomyelin phosphodiesterase-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 long SRA reads, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
sphingomyelin phosphodiesterase-like isoform X1
sphingomyelin phosphodiesterase-like isoform X2
sphingomyelin phosphodiesterase-like isoform X3
integrator complex subunit 11-like, transcript variant X2
integrator complex subunit 11-like, transcript variant X1
dynein heavy chain, cytoplasmic-like, transcript variant X4
dynein heavy chain, cytoplasmic-like, transcript variant X3
dynein heavy chain, cytoplasmic-like, transcript variant X2
dynein heavy chain, cytoplasmic-like, transcript variant X1
dynein heavy chain, cytoplasmic-like isoform X4
dynein heavy chain, cytoplasmic-like isoform X3
dynein heavy chain, cytoplasmic-like isoform X2
dynein heavy chain, cytoplasmic-like isoform X1
activin receptor type-2A-like, transcript variant X4
activin receptor type-2A-like, transcript variant X1
activin receptor type-2A-like, transcript variant X2
activin receptor type-2A-like, transcript variant X7
activin receptor type-2A-like, transcript variant X5
activin receptor type-2A-like, transcript variant X6
activin receptor type-2A-like, transcript variant X3
activin receptor type-2A-like isoform X2
activin receptor type-2A-like isoform X1
activin receptor type-2A-like isoform X3
probable isocitrate dehydrogenase [NAD] subunit alpha, mitochondrial
NADH-ubiquinone oxidoreductase 49 kDa subunit-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
LOW QUALITY PROTEIN: PHD finger protein 12-like
RING-type E3 ubiquitin-protein ligase PPIL2-like, transcript variant X2
RING-type E3 ubiquitin-protein ligase PPIL2-like, transcript variant X1
RING-type E3 ubiquitin-protein ligase PPIL2-like
probable small nuclear ribonucleoprotein Sm D1
protein yippee-like 2, transcript variant X2
protein yippee-like 2, transcript variant X1
protein yippee-like 2, transcript variant X3
zinc finger protein 347-like, transcript variant X4
zinc finger protein 347-like, transcript variant X2
zinc finger protein 347-like, transcript variant X1
zinc finger protein 347-like, transcript variant X3
beta-1,4-glucuronyltransferase 1-like, transcript variant X5
beta-1,4-glucuronyltransferase 1-like, transcript variant X1
beta-1,4-glucuronyltransferase 1-like, transcript variant X2
beta-1,4-glucuronyltransferase 1-like, transcript variant X3
beta-1,4-glucuronyltransferase 1-like isoform X1
beta-1,4-glucuronyltransferase 1-like isoform X2
beta-1,4-glucuronyltransferase 1-like isoform X3
beta-1,4-glucuronyltransferase 1-like, transcript variant X4
LOW QUALITY PROTEIN: uncharacterized protein LOC123506043
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 74% coverage of the annotated genomic feature by RNAseq alignments
phosphoribosylformylglycinamidine synthase-like
uncharacterized LOC123506034, transcript variant X4
uncharacterized LOC123506034, transcript variant X3
uncharacterized LOC123506034, transcript variant X2
uncharacterized LOC123506034, transcript variant X1
uncharacterized protein LOC123506034 isoform X3
uncharacterized protein LOC123506034 isoform X4
uncharacterized protein LOC123506034 isoform X2
uncharacterized protein LOC123506034 isoform X1
uncharacterized LOC123506035, transcript variant X4
uncharacterized LOC123506035, transcript variant X1
uncharacterized LOC123506035, transcript variant X3
uncharacterized LOC123506035, transcript variant X2
uncharacterized protein LOC123506035 isoform X1
uncharacterized protein LOC123506035 isoform X2
protein takeout-like, transcript variant X1
protein takeout-like, transcript variant X2
SLIT-ROBO Rho GTPase-activating protein 1-like, transcript variant X4
SLIT-ROBO Rho GTPase-activating protein 1-like, transcript variant X3
SLIT-ROBO Rho GTPase-activating protein 1-like isoform X2
SLIT-ROBO Rho GTPase-activating protein 1-like, transcript variant X9
SLIT-ROBO Rho GTPase-activating protein 1-like, transcript variant X10
SLIT-ROBO Rho GTPase-activating protein 1-like, transcript variant X8
SLIT-ROBO Rho GTPase-activating protein 1-like, transcript variant X13
SLIT-ROBO Rho GTPase-activating protein 1-like isoform X6
SLIT-ROBO Rho GTPase-activating protein 1-like isoform X8
SLIT-ROBO Rho GTPase-activating protein 1-like, transcript variant X12
SLIT-ROBO Rho GTPase-activating protein 1-like, transcript variant X11
SLIT-ROBO Rho GTPase-activating protein 1-like isoform X7
transfer RNA asparagine (anticodon GUU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA lysine (anticodon CUU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
SLIT-ROBO Rho GTPase-activating protein 1-like, transcript variant X16
SLIT-ROBO Rho GTPase-activating protein 1-like, transcript variant X2
SLIT-ROBO Rho GTPase-activating protein 1-like isoform X11
SLIT-ROBO Rho GTPase-activating protein 1-like, transcript variant X14
SLIT-ROBO Rho GTPase-activating protein 1-like isoform X9
SLIT-ROBO Rho GTPase-activating protein 1-like, transcript variant X15
SLIT-ROBO Rho GTPase-activating protein 1-like isoform X10
SLIT-ROBO Rho GTPase-activating protein 1-like, transcript variant X5
SLIT-ROBO Rho GTPase-activating protein 1-like, transcript variant X7
SLIT-ROBO Rho GTPase-activating protein 1-like, transcript variant X1
SLIT-ROBO Rho GTPase-activating protein 1-like, transcript variant X17
SLIT-ROBO Rho GTPase-activating protein 1-like, transcript variant X6
SLIT-ROBO Rho GTPase-activating protein 1-like isoform X1
SLIT-ROBO Rho GTPase-activating protein 1-like isoform X12
SLIT-ROBO Rho GTPase-activating protein 1-like isoform X4
SLIT-ROBO Rho GTPase-activating protein 1-like isoform X3
SLIT-ROBO Rho GTPase-activating protein 1-like isoform X5
glucoside xylosyltransferase 1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
glucoside xylosyltransferase 1-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 long SRA reads, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
glucoside xylosyltransferase 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 long SRA reads, 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
glucoside xylosyltransferase 1-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 long SRA reads, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
glucoside xylosyltransferase 1-like isoform X3
glucoside xylosyltransferase 1-like isoform X4
glucoside xylosyltransferase 1-like isoform X2
glucoside xylosyltransferase 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
glucoside xylosyltransferase 1-like isoform X5
glucoside xylosyltransferase 1-like isoform X1
UDP-glucose 4-epimerase-like, transcript variant X4
UDP-glucose 4-epimerase-like, transcript variant X3
UDP-glucose 4-epimerase-like, transcript variant X2
UDP-glucose 4-epimerase-like, transcript variant X1
uncharacterized LOC123506332, transcript variant X2
uncharacterized LOC123506332, transcript variant X3
uncharacterized LOC123506332, transcript variant X1
uncharacterized LOC123506332, transcript variant X4
uncharacterized LOC123506332, transcript variant X5
uncharacterized protein LOC123506332 isoform X2
uncharacterized protein LOC123506332 isoform X1
uncharacterized protein LOC123506332 isoform X4
uncharacterized protein LOC123506332 isoform X3
putative tricarboxylate transport protein, mitochondrial
LOW QUALITY PROTEIN: putative tricarboxylate transport protein, mitochondrial